Willim Stemmer has joined the scientific advisory board of Copenhagen, Denmark-based Nuevolution. Stemmer is the founder of Maygen, Avidia, and Genetic Designs, and previously worked at Affymax Research Institute, as well as Hybritech. Stemmer holds a PhD from the University of Wisconsin-Madison.
Nina Siegler was named managing director of life sciences for the Bethesda, Md.-based investment bank, National Capital. Siegler was an equities analyst for such companies as Paine Webber and Prudential Bache and also worked at the National Institutes of Health and the office of technology transfer at Johns Hopkins University. She holds an MBA from the University of Virginia, and a BS in biology from the University of North Carolina.
Alexander Bondar was named executive director for biotechnology business development for Jupiter, Fla.–based Dyadic, an industrial enzyme maker that now offers gene and protein research services. Bondar previously was employed in the life sciences group of the Aurora Funds, a Research Triangle Park, NC-based venture capital firm. He holds an MBA from Duke University.